Abstract
The epithelial to mesenchymal transition (EMT) is a cellular program that is involved in embryonic development; wound healing, but also in tumorigenesis. Breast carcinoma (BC) is the most common cancer in women worldwide, and the majority of deaths (90%) are caused by invasion and metastasis. The EMT plays an important role in invasion and subsequent metastasis. Several distinct biological events integrate a cascade that leads not only to a change from an epithelial to mesenchymal phenotype, but allows for detachment, migration, invasion and ultimately, colonization of a second site. Understanding the biological intricacies of the EMT may provide important insights that lead to the development of therapeutic targets in pre-invasive and invasive breast cancer, and could be used as biomarkers identifying tumor subsets with greater chances of recurrence, metastasis and therapeutic resistance leading to death.
Author supplied keywords
Cite
CITATION STYLE
Lima, J. F., Nofech-Mozes, S., Bayani, J., & Bartlett, J. M. S. (2016, July 1). EMT in breast carcinoma—A review. Journal of Clinical Medicine. MDPI. https://doi.org/10.3390/jcm5070065
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.